CORC

浏览/检索结果: 共2条,第1-2条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern 会议论文
BLOOD, 2018-11-29
作者:  Cortes, Jorge E.;  Jiang, Qian;  Wang, Jianxiang;  Weng, Jianyu;  Zhu, Huanling
收藏  |  浏览/下载:11/0  |  提交时间:2020/01/03
HIGHER RATE OF MAJOR MOLECULAR RESPONSE (MMR) WITH NILOTINIB vs IMATINIB IN CHINESE PATIENTS (PTS) WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTCHINA 24-MO UPDATE 会议论文
HAEMATOLOGICA, 2014-06-01
作者:  Shen, Z. X.;  Huang, X.;  Baccarani, M.;  Ortmann, C. E.;  Hertle, S.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace